Given its molecular impact and its link to CLL as well as the fact that AXIN2 has been proposed to function as a tumor-suppressor gene34, we hypothesized that this indel may confer differential susceptibility to CLL. The gene discussed is AXIN2; the disease is B-cell chronic lymphocytic leukemia.